Search

Your search keyword '"Benninga, M"' showing total 751 results
Start Over Author "Benninga, M"
751 results on '"Benninga, M"'

1. Fecal amine metabolite analysis before onset of severe necrotizing enterocolitis in preterm infants: a prospective case–control study

Author

Deianova, N., el Manouni el Hassani, S., Struijs, E. A., Jansen, E. E. W., Bakkali, A., van de Wiel, M. A., de Boode, W. P., Hulzebos, C. V., van Kaam, A. H., Kramer, B. W., d’Haens, E., Vijlbrief, D. C., van Weissenbruch, M. M., de Jonge, W. J., Benninga, M. A., Niemarkt, H. J., de Boer, N. K. H., and de Meij, T. G. J.

Published
2022
Full Text
View/download PDF

7. Coeliakie

Author

Schweizer, J. J., Wauters, E. A. K., Benninga, M. A., van Aalderen, W. M. C., de Blécourt, A C. E., Benninga, M. A., Didden, R., Elich, M., de Faber, J. T. H. N., de Graaf, E. A. B., Gringhuis, D., de Groot, I. J. M., Heineman-de Boer, J. A., Hendriks, J. J. E., Hendriks-Hofman, P. J., Jennekens-Schinkel, A., Kamphuis, R. P., Knoors, H., Last, B. F., Moonen, J. M. G., de Moor, J. M. H., Reeser, H. M., Schweizer, J. J., Siderius, E. J., Sinnema, G., Sprikkelman, A. B., Swanenburg de Veye, H. F. N., Wauters, E. A. K., Weber, J. W., and van Woudenberg, P. A.

Published
2010
Full Text
View/download PDF

11. P076 Abdominal pain severity for IBD in remission correlates with genetic clustering and enzymatic activity of faeces-derived Candida albicans strains

Author

Van Thiel, I, primary, Maasland, T, additional, van Wassenaer, E, additional, Hoekman, D, additional, Spooren, C, additional, Hakvoort, T, additional, Admiraal, I, additional, Theelen, B, additional, Levin, E, additional, Benninga, M, additional, Jonkers, D, additional, D'Haens, G, additional, Rosendahl, S, additional, Boekhout, T, additional, Hagen, F, additional, de Jonge, W, additional, and van den Wijngaard, R, additional

Published
2023
Full Text
View/download PDF

17. An ESPGHAN Position Paper on the Use of Low-FODMAP Diet in Pediatric Gastroenterology

Author

Thomassen, R A, Luque, V, Assa, A, Borrelli, O, Broekaert, I, Dolinsek, J, Martin-de-Carpi, J, Mas, E, Miele, E, Norsa, L, Ribes-Koninckx, C, Saccomani, M Deganello, Thomson, M, Tzivinikos, C, Verduci, E, Bronsky, J, Haiden, N, Köglmeier, J, de Koning, B, Benninga, M A, Pediatrics, Paediatric Gastroenterology, Amsterdam Gastroenterology Endocrinology Metabolism, Amsterdam Reproduction & Development (AR&D), Oslo University Hospital [Oslo], Universitat Rovira i Virgili, The Hebrew University of Jerusalem (HUJ), Great Ormond Street Hospital for Children [London] (GOSH), University Hospital of Cologne [Cologne], University of Maribor, University of Barcelona, Institut de Recherche en Santé Digestive (IRSD ), Université Toulouse III - Paul Sabatier (UT3), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-Ecole Nationale Vétérinaire de Toulouse (ENVT), Institut National Polytechnique (Toulouse) (Toulouse INP), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-Institut National Polytechnique (Toulouse) (Toulouse INP), Université Fédérale Toulouse Midi-Pyrénées-Institut National de la Santé et de la Recherche Médicale (INSERM)-Institut National de Recherche pour l’Agriculture, l’Alimentation et l’Environnement (INRAE), University of Naples Federico II = Università degli studi di Napoli Federico II, ASST Papa Giovanni XXIII [Bergamo, Italy], Hospital Universitari i Politècnic La Fe = University and Polytechnic Hospital La Fe, Inst Invest Sanitaria La FE, Sheffield Children's NHS Foundation Trust, Mohammed Bin Rashid University of Medicine and Health Sciences (MBRU), Università degli Studi di Milano = University of Milan (UNIMI), University Hospital Motol [Prague], Medizinische Universität Wien = Medical University of Vienna, Erasmus University Rotterdam, University of Amsterdam [Amsterdam] (UvA), SEGUIN, Nathalie, Thomassen, R A, Luque, V, Assa, A, Borrelli, O, Broekaert, I, Dolinsek, J, Martin-de-Carpi, J, Mas, E, Miele, E, Norsa, L, Ribes-Koninckx, C, Saccomani, M Deganello, Thomson, M, Tzivinikos, C, Verduci, E, Bronsky, J, Haiden, N, Köglmeier, J, de Koning, B, and Benninga, M A

Subjects
IRRITABLE-BOWEL-SYNDROME, Oligosaccharides, CHILDREN, Disaccharides, POLYOLS DIET, CLINICAL-TRIAL, Irritable Bowel Syndrome, Diet, Carbohydrate-Restricted, [SDV.MHEP.PED] Life Sciences [q-bio]/Human health and pathology/Pediatrics, QUALITY-OF-LIFE, MANAGEMENT, Humans, Settore MED/49 - Scienze Tecniche Dietetiche Applicate, REDUCES SYMPTOMS, Child, Settore MED/38 - Pediatria Generale e Specialistica, [SDV.MHEP.PED]Life Sciences [q-bio]/Human health and pathology/Pediatrics, [SDV.MHEP] Life Sciences [q-bio]/Human health and pathology, Monosaccharides, Gastroenterology, RANDOMIZED CONTROLLED-TRIAL, Diet, [SDV.AEN] Life Sciences [q-bio]/Food and Nutrition, Fermentation, Pediatrics, Perinatology and Child Health, LOW FERMENTABLE OLIGOSACCHARIDES, [SDV.AEN]Life Sciences [q-bio]/Food and Nutrition, [SDV.MHEP]Life Sciences [q-bio]/Human health and pathology, CELIAC GLUTEN SENSITIVITY, Systematic Reviews as Topic
Abstract

OBJECTIVES: Excluding oligo-, di-, monosaccharides and polyols (FODMAPs) from the diet is increasingly being used to treat children with gastrointestinal complaints. The aim of this position paper is to review the available evidence on the safety and efficacy of its use in children and provide expert guidance regarding practical aspects in case its use is considered. METHODS: Members of the Gastroenterology Committee, the Nutrition Committee and the Allied Health Professionals Committee of the European Society for Pediatric Gastroenterology Hepatology and Nutrition (ESPGHAN) contributed to this position paper. Clinical questions regarding initiation, introduction, duration, weaning, monitoring, professional guidance, safety and risks of the diet are addressed. A systematic literature search was performed from 2005 to May 2021 using PubMed, MEDLINE and Cochrane Database of Systematic Reviews. In the absence of evidence, recommendations reflect the expert opinion of the authors. RESULTS: The systematic literature search revealed that the low-FODMAP diet has not been comprehensively studied in children. Indications and contraindications of the use of the diet in different pediatric gastroenterological conditions are discussed and practical recommendations are formulated. CONCLUSIONS: There is scarce evidence to support the use of a low-FODMAP diet in children with Irritable Bowel Syndrome and no evidence to recommend its use in other gastrointestinal diseases and complaints in children. Awareness of how and when to use the diet is crucial, as a restrictive diet may impact nutritional adequacy and/or promote distorted eating in vulnerable subjects. The present manuscript provides practical safety tips to be applied when the low-FODMAP diet is considered in children.

Published
2022

23. An ESPGHAN position paper on the use of low-FODMAP diet in pediatric gastroenterology

Author

Thomassen, R. A., Luque, V, Assa, A., Borrelli, O., Broekaert, I, Dolinsek, J., Martin-de-Carpi, J., Mas, E., Miele, E., Norsa, L., Ribes-Koninckx, C., Saccomani, M. Deganello, Thomson, M., Tzivinikos, C., Verduci, E., Bronsky, J., Haiden, N., Koglmeier, J., de Koning, B., Benninga, M. A., Thomassen, R. A., Luque, V, Assa, A., Borrelli, O., Broekaert, I, Dolinsek, J., Martin-de-Carpi, J., Mas, E., Miele, E., Norsa, L., Ribes-Koninckx, C., Saccomani, M. Deganello, Thomson, M., Tzivinikos, C., Verduci, E., Bronsky, J., Haiden, N., Koglmeier, J., de Koning, B., and Benninga, M. A.

Abstract

Excluding oligo-, di-, monosaccharides and polyols (FODMAPs) from the diet is increasingly being used to treat children with gastrointestinal complaints. The aim of this position paper is to review the available evidence on the safety and efficacy of its use in children and provide expert guidance regarding practical aspects in case its use is considered . Members of the Gastroenterology Committee, the Nutrition Committee and the Allied Health Professionals Committee of the European Society for Pediatric Gastroenterology Hepatology and Nutrition contributed to this position paper. Clinical questions regarding initiation, introduction, duration, weaning, monitoring, professional guidance, safety and risks of the diet are addressed. A systematic literature search was performed from 2005 to May 2021 using PubMed, MEDLINE and Cochrane Database of Systematic Reviews. In the absence of evidence, recommendations reflect the expert opinion of the authors. The systematic literature search revealed that the low-FODMAP diet has not been comprehensively studied in children. Indications and contraindications of the use of the diet in different pediatric gastroenterological conditions are discussed and practical recommendations are formulated. There is scarce evidence to support the use of a low-FODMAP diet in children with Irritable Bowel Syndrome and no evidence to recommend its use in other gastrointestinal diseases and complaints in children. Awareness of how and when to use the diet is crucial, as a restrictive diet may impact nutritional adequacy and/or promote distorted eating in vulnerable subjects. The present article provides practical safety tips to be applied when the low-FODMAP diet is considered in children.

Published
2022

24. Fecal amine metabolite analysis before onset of severe necrotizing enterocolitis in preterm infants: a prospective case-control study

Author

MS Neonatologie, Child Health, Deianova, N, El Manouni El Hassani, S, Struijs, E A, Jansen, E E W, Bakkali, A, van de Wiel, M A, de Boode, Willem P, Hulzebos, C V, van Kaam, A H, Kramer, B W, d'Haens, E, Vijlbrief, D C, van Weissenbruch, M M, de Jonge, W J, Benninga, M A, Niemarkt, H J, de Boer, N K H, de Meij, T G J, MS Neonatologie, Child Health, Deianova, N, El Manouni El Hassani, S, Struijs, E A, Jansen, E E W, Bakkali, A, van de Wiel, M A, de Boode, Willem P, Hulzebos, C V, van Kaam, A H, Kramer, B W, d'Haens, E, Vijlbrief, D C, van Weissenbruch, M M, de Jonge, W J, Benninga, M A, Niemarkt, H J, de Boer, N K H, and de Meij, T G J

Published
2022

29. P711 Stool microbiome communities predict remission in pediatric Crohn’s disease patients even after start of treatment

Author

Verburgt, C, primary, Dunn, K A, additional, Bielawski, J P, additional, Otley, A R, additional, Heyman, M B, additional, Sunseri, W, additional, Shouval, D, additional, Levine, A, additional, de Meij, T, additional, Hyams, J S, additional, Denson, L A, additional, Kugathasan, S, additional, Benninga, M A, additional, de Jonge, W J, additional, and Van Limbergen, J E, additional

Published
2022
Full Text
View/download PDF

33. Chronic constipation in adults: Contemporary perspectives and clinical challenges. 1: Epidemiology, diagnosis, clinical associations, pathophysiology and investigation

Author

Scott, S M, Farmer, A D, Dinning, P G, Carrington, E V, Benninga, M A, Burgell, R E, Dimidi, E, Fikree, A, Ford, A C, Fox, M, Hoad, C L, Knowles, C H, Krogh, K, Nugent, K, Remes-Troche, J M, Whelan, K, and Corsetti, M

Subjects
chronic constipation, diagnosis, epidemiology, IBS-C, investigation, pathophysiology
Abstract

Chronic constipation is a prevalent disorder that affects patients’ quality of life and consumes resources in healthcare systems worldwide. In clinical practice, it is still considered a challenge as clinicians frequently are unsure as to which treatments to use and when. Over a decade ago, a Neurogastroenterology & Motility journal supplement devoted to the investigation and management of constipation was published (2009;21(Suppl.2)). This included seven articles, disseminating all themes covered during a preceding two-day meeting held in London, entitled ‘Current perspectives in chronic constipation: a scientific and clinical symposium’. In October 2018, the 3rd London Masterclass, entitled ‘Contemporary management of constipation’ was held, again over two days. All faculty members were invited to author two new review articles representing a collective synthesis of talks presented and discussions held during this meeting. PURPOSEThis article represents the first of these reviews, addressing epidemiology, diagnosis, clinical associations, pathophysiology and investigation. Clearly not all aspects of the condition can be covered in adequate detail; hence, there is a focus on particular ‘hot topics’ and themes that are of contemporary interest. The second review addresses management of chronic constipation, covering behavioural, conservative, medical and surgical therapies.

Published
2021

38. Bowel Lengthening Procedures in Children with Short Bowel Syndrome: A Systematic Review.

Author

Nagelkerke, Sjoerd C. J., Poelgeest, M. Y. van, Wessel, L. M., Mutanen, A., Langeveld, H. R., Hill, S., Benninga, M. A., Tabbers, M. M., Bakx, R., and ERNICA Intestinal Failure Working Group

Subjects
INTESTINAL surgery, RETROSPECTIVE studies, TREATMENT effectiveness, DIGESTIVE organ surgery, PARENTERAL feeding, SHORT bowel syndrome, LONGITUDINAL method
Abstract

Introduction:  The aims of the study are to systematically assess and critically appraise the evidence concerning two surgical techniques to lengthen the bowel in children with short bowel syndrome (SBS), namely, the longitudinal intestinal lengthening and tailoring (LILT) and serial transverse enteroplasty (STEP), and to identify patient characteristics associated with a favorable outcome.Materials and Methods:  MEDLINE, EMBASE, and Cochrane Central Register of Controlled Trials (CENTRAL) databases were searched from inception till December 2019. No language restriction was used.Results:  In all, 2,390 articles were found, of which 40 were included, discussing 782 patients. The median age of the patients at the primary bowel lengthening procedure was 16 months (range: 1-84 months). Meta-analysis could not be performed due to the incomparability of the groups, due to heterogeneous definitions and outcome reporting. After STEP, 46% of patients weaned off parenteral nutrition (PN) versus 52% after LILT. Mortality was 7% for STEP and 26% for LILT. Patient characteristics predictive for success (weaning or survival) were discussed in nine studies showing differing results. Quality of reporting was considered poor to fair.Conclusion:  LILT and STEP are both valuable treatment strategies used in the management of pediatric SBS. However, currently it is not possible to advise surgeons on accurate patient selection and to predict the result of either intervention. Homogenous, prospective, outcome reporting is necessary, for which an international network is needed. [ABSTRACT FROM AUTHOR]

Published
2022
Full Text
View/download PDF

42. OP32 Stool microbiome communities predict remission in treatment-naïve Pediatric Crohn’s Disease patients

Author

Verburgt, C, primary, Dunn, K, additional, Bielawski, J, additional, Otley, A, additional, Heyman, M, additional, Sunseri, W, additional, Shouval, D, additional, Levine, A, additional, de Meij, T, additional, Hyams, J, additional, Denson, L, additional, Kugathasan, S, additional, Benninga, M, additional, de Jonge, W, additional, and Van Limbergen, J, additional

Published
2021
Full Text
View/download PDF

48. A Systematic Review and Meta-analysis of Paediatric Inflammatory Bowel Disease Incidence and Prevalence Across Europe

Author

Roberts, S. E., Thorne, K., Thapar, N., Broekaert, I., Benninga, M. A., Dolinsek, J., Mas, E., Miele, E., Orel, R., Pienar, C., Ribes-Koninckx, C., Thomson, M., Tzivinikos, C., Morrison-Rees, S., John, A., Williams, J. G., Roberts, S. E., Thorne, K., Thapar, N., Broekaert, I., Benninga, M. A., Dolinsek, J., Mas, E., Miele, E., Orel, R., Pienar, C., Ribes-Koninckx, C., Thomson, M., Tzivinikos, C., Morrison-Rees, S., John, A., and Williams, J. G.

Abstract

Background and Aims: Inflammatory bowel disease [IBD] is often one of the most devastating and debilitating chronic gastrointestinal disorders in children and adolescents. The main objectives here were to systematically review the incidence and prevalence of paediatric IBD across all 51 European states. Methods: We undertook a systematic review and meta-analysis based on PubMed, CINAHL, the Cochrane Library, searches of reference lists, grey literature and websites, covering the period from 1970 to 2018. Results: Incidence rates for both paediatric Crohn's disease [CD] and ulcerative colitis [UC] were higher in northern Europe than in other European regions. There have been large increases in the incidence of both paediatric CD and UC over the last 50 years, which appear widespread across Europe. The largest increases for CD have been reported from Sweden, Wales, England, the Czech Republic, Denmark and Hungary, and for UC from the Czech Republic, Ireland, Sweden and Hungary. Incidence rates for paediatric CD have increased up to 9 or 10 per 100 000 population in parts of Europe, including Scandinavia, while rates for paediatric UC are often slightly lower than for CD. Prevalence reported for CD ranged from 8.2 per 100 000 to approximately 60 and, for UC, from 8.3 to approximately 30. Conclusions: The incidence of paediatric IBD continues to increase throughout Europe. There is stronger evidence of a north-south than an east-west gradient in incidence across Europe. Further prospective studies are needed, preferably multinational and based on IBD registries, using standardized definitions, methodology and timescales.

Published
2020

Catalog

Books, media, physical & digital resources
See catalog results